Insider Transactions in Q2 2025 at Lexicon Pharmaceuticals, Inc. (LXRX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 13
2025
|
Sam L Barker Director |
BUY
Exercise of conversion of derivative security
|
Direct |
36,810
+22.83%
|
-
|
|
May 13
2025
|
Christopher J Sobecki Director |
BUY
Exercise of conversion of derivative security
|
Direct |
36,810
+15.29%
|
-
|
|
May 13
2025
|
Diane E. Sullivan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
36,810
+50.0%
|
-
|
|
May 13
2025
|
Judith L Swain Director |
BUY
Exercise of conversion of derivative security
|
Direct |
36,810
+30.18%
|
-
|
|
May 13
2025
|
Raymond Debbane Director |
BUY
Exercise of conversion of derivative security
|
Direct |
36,810
+2.59%
|
-
|
|
May 13
2025
|
Philippe Amouyal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
36,810
+11.43%
|
-
|